Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ MAGEA2 Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA599765
Description
Antibody detects endogenous levels of total MAGEA2.
MAGEA2 is a member of the MAGEA gene family. The members of this family have their entire coding sequences located in the last exon, and the encoded proteins show 50 to 80% sequence identity between each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are expressed at a high level in a number of tumors of various histologic types, and are silent in normal tissues with the exception of testis and placenta. The MAGEA genes are clustered on chromosome Xq28. They may be implicated in some hereditary disorders, such as dyskeratosis congenita. This gene has two identical copies at different loci.
Specifications
MAGEA2 | |
Polyclonal | |
Unconjugated | |
MAGEA2 | |
Cancer/testis antigen 1.2; cancer/testis antigen family 1, member 2; CT1.2; MAGE family member A2; MAGE2; MAGE-2 antigen; MAGEA2; MAGEA2A; MAGEA2B; melanoma antigen 2; melanoma antigen family A, 2; melanoma antigen family A2; melanoma-associated antigen 2; MGC131923 | |
Rabbit | |
Affinity Chromatography | |
RUO | |
4101 | |
-20°C | |
Liquid |
Western Blot | |
1 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
P43356 | |
MAGEA2 | |
A synthesized peptide derived from human MAGEA2; MAGEA2B(Accession P43356), corresponding to amino acid residues P266-E314. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction